Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

The 765G>C Polymorphism in the Cyclooxygenase-2 Gene and Gastric Cancer Risk: an Update by Meta-analysis

  • Zhao, Fen (Department of Pathophysiology, West China School of Preclinical and Forensic Medicine, Sichuan University) ;
  • Zhu, Hong (Department of Abdominal Cancer, West China Hospital, Sichuan University) ;
  • Huang, Min (Department of Pathophysiology, West China School of Preclinical and Forensic Medicine, Sichuan University) ;
  • Yi, Cheng (Department of Abdominal Cancer, West China Hospital, Sichuan University) ;
  • Huang, Ying (Department of Pathophysiology, West China School of Preclinical and Forensic Medicine, Sichuan University)
  • Published : 2014.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The 765G>C polymorphism in cyclooxygenase-2 (COX-2) gene has been extensively investigated for association with gastric cancer (GC). However, the results of different studies have been inconsistent. The aim of this study is to comprehensively evaluate the genetic risk of -765G>C polymorphism in the COX-2 gene for GC. Materials and Methods: We searched Pubmed, Embase, Medline, CNKI database, Wanfang database, Weipu database, and Chinese Biomedical database, covering all publications (last search been performed on Jan 10, 2014). Statistical analyses were performed using Revman 5.2 and STATA 10.0 software. Results: A total of 1,874 cases and 3,005 controls in 10 case-control studies were included in this meta-analysis. The results indicated that the variant C allele carriers (GC+CC) had a 69% increased risk of GC when compared with the homozygote GG (odds ratio (OR)=1.69, 95% confidence interval (CI), 1.10-2.61 for GC+CC vs GG). In the subgroup analysis by ethnicity, significant elevated risks were associated with C allele carriers in Asians (OR=1.75, 95%CI=1.40-2.18, and p<0.00001) and in Indians (OR=8.38, 95%CI=4.34-16.16, and p<0.00001) but not in Caucasians (OR=1.07, 95%CI=0.81-1.42, and p=0.62) or in Dutch (OR=0.53, 95%CI= 0.33-0.87, and p= 0.01).In the subgroup analysis by Helicobacter pylori (H. pylori) status, a significantly increased risk was identified among H. pylori (+) (OR=3.58, 95%CI=2.33-3.50, and p<0.00001) and H. pylori (-) (OR=2.32, 95%CI=1.46-3.69, and p=0.0004). Conclusions: This meta-analysis suggested that the -765G>C polymorphism in the COX-2 gene could be a risk factor for GC in Asians and Indians.

Keywords

References

  1. Ajani JA, Bentrem DJ, Besh S, et al (2013). Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw, 11, 531-46.
  2. Bakhle YS (2001). COX-2 and cancer: a new approach to an old problem. Br J Pharmacol, 134, 1137-50. https://doi.org/10.1038/sj.bjp.0704365
  3. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  4. Berlau J, Glei M, Pool-Zobel BL, et al (2004). Colon cancer risk factors from nutrition. Anal Bioanal Chem, 378, 737-43. https://doi.org/10.1007/s00216-003-2284-4
  5. Cao Y, Prescott SM (2002). Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol, 190, 279-86. https://doi.org/10.1002/jcp.10068
  6. Chen XJ, Li N, Huang YD, et al (2014). Factors for postoperative gallstone occurrence in patients with gastric cancer: a metaanalysis. Asian Pac J Cancer Prev, 15, 877-81. https://doi.org/10.7314/APJCP.2014.15.2.877
  7. Cook MB, Kamangar F, Whiteman DC, et al (2010). Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst, 102, 1344-53. https://doi.org/10.1093/jnci/djq289
  8. Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62.
  9. Egger M, Davey SG, Schneider M, et al (1997). Bias in metaanalysis detected by a simple, graphical test. BMJ, 13, 629-34.
  10. Goto Y, Ando T, Nishio K, et al (2005). The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pac J Cancer Prev, 6, 464-7.
  11. Gu KS, Chen Y (2012). Mechanism of P-glycoprotein expression in the SGC7901 human gastric adenocarcinoma cell line induced by cyclooxygenase-2. Asian Pac J Cancer Prev, 13, 2379-83. https://doi.org/10.7314/APJCP.2012.13.5.2379
  12. Hou L, Grillo P, Zhu ZZ, et al (2007). COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population. Anticancer Res, 27, 4243-7.
  13. Jiang GJ, Wang HM, Zhou Y, et al (2007). The correlation study between the nucleotide polymorphisms of cyclooxygenase-2 gene and the susceptibility to gastric cancer. Acta Univ Med Nanjing, 27, 890-4.
  14. Kamangar F, Dores GM, Anderson WF, et al (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50. https://doi.org/10.1200/JCO.2005.05.2308
  15. Li Y, Dai L, Zhang J, et al (2012). Cyclooxygenase-2 polymorphisms and the risk of gastric cancer in various degrees of relationship in the Chinese Han population. Oncol Lett, 3, 107-12.
  16. Li YJ, Zhang ZY, Mao YY, et al (2014). A genetic variant in MiR- 146a modifies digestive system cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 15, 145-50. https://doi.org/10.7314/APJCP.2014.15.1.145
  17. Liu F, Pan K, Zhang X, et al (2006). Genetic variants in cyclooxygenase-2: expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology, 130, 1975-84. https://doi.org/10.1053/j.gastro.2006.03.021
  18. Liu JL, Liang Y, Wang ZN, et al (2010). Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: a meta-analysis. World J Gastroenterol, 16, 5510-7. https://doi.org/10.3748/wjg.v16.i43.5510
  19. Liu JW, He CY, Sun LP, et al (2013). The DNA repair gene ERCC6 rs1917799 polymorphism is associated with gastric cancer risk in Chinese. Asian Pac J Cancer Prev, 14, 6103-8. https://doi.org/10.7314/APJCP.2013.14.10.6103
  20. Murata H, Kawano S, Tsuji S, et al (1999). Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol, 94, 451-55. https://doi.org/10.1111/j.1572-0241.1999.876_e.x
  21. Ohno R, Yoshinaga K, Fujita T, et al (2001). Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer, 91, 1876-81. https://doi.org/10.1002/1097-0142(20010515)91:10<1876::AID-CNCR1209>3.0.CO;2-H
  22. Pereira C, Sousa H, Ferreira P, et al (2006). -765G>C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World J Gastroenterol, 12, 5473-8.
  23. Saxena A, Prasad KN, Ghoshal UC, et al (2008). Polymorphism of -765G>C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H. pylori infection: a study from northern India. World J Gastroenterol, 14, 1498-503. https://doi.org/10.3748/wjg.14.1498
  24. Sethi G, Shanmugam MK, Ramachandran L, et al (2012). Multifaceted link between cancer and inflammation. Biosci Rep, 32, 1-15. https://doi.org/10.1042/BSR20100136
  25. Shibata T, Tahara T, Yonemura J, et al (2010). The G-protein $\beta$3 polymorphism is associated with diffuse type gastric cancer in Japanese. Asian Pac J Cancer Prev, 11, 1195-9.
  26. Shin WG, Kim HJ, Cho SJ, et al (2012). The COX-2-1195AA genotype is associated with diffuse-type gastric cancer in Korea. Gut Liver, 6, 321-7. https://doi.org/10.5009/gnl.2012.6.3.321
  27. Siegel R, Naishadham D, Jemal A, et al (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
  28. Sitarz R, Leguit RJ, de Leng WW, et al (2008). The COX-2 promoter polymorphism -765 G4C is associated with earlyonset, conventional and stump gastric cancers. Mod Pathol, 21, 685-90. https://doi.org/10.1038/modpathol.2008.36
  29. Szczeklik W, SanakSzczeklik W, Sanak M, et al (2004). Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol, 114, 248-53. https://doi.org/10.1016/j.jaci.2004.05.030
  30. Tang XF, Li YM, Li SX, et al (2009). Correlation between the nucleotide polymorphisms of cox-2 and the susceptibility to gastric cancer in Hui ethnic group. Shi Jie Hua Ren Xiao Hua Za Zhi, 17, 1772-6.
  31. Tatsuguchi A, Matsui K, Shinji Y, et al (2004). Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol, 35, 488-95. https://doi.org/10.1016/j.humpath.2003.10.025
  32. Uefuji K, Ichikura T, Mochizuki H, et al (2000). Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res, 6, 135-38.
  33. Wang C, Yuan Y, Hunt RH, et al (2007). The association between Helicobacter pylori infection and early gastric cancer: a metaanalysis. Am J Gastroenterol, 102, 1789-98. https://doi.org/10.1111/j.1572-0241.2007.01335.x
  34. Wang XF, Huang MZ, Zhang XW, et al (2013). COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis. PloS One, 8, 73213. https://doi.org/10.1371/journal.pone.0073213
  35. Yaghoobi M, Rakhshani N, Sadr F, et al (2004). Hereditary risk factors for the development of gastric cancer in younger patients. BMC Gastroenterol, 4, 28. https://doi.org/10.1186/1471-230X-4-28
  36. Yan WF, Sun PC, Nie CF, et al (2013). Cyclooxygenase-2 polymorphisms were associated with the risk of gastric cancer: evidence from a meta-analysis based on case-control studies. Tumour Biol, 34, 3323-30. https://doi.org/10.1007/s13277-013-0901-1
  37. Zhang XM, Miao XP, Tan W, et al (2006). Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer. Zhongguo Yixue Kexueyuan Xuebao, 28, 119-23.
  38. Zhang D (2009). The COX-2-765G>C and PARP-l Val762Ala genes polymorphisms and gastric cancer risk in high and low incidence areas of Gansu Province (D). Gan Su: Department of General Surgery, Clinical Medicine, Lanzhou University, 1-47.
  39. Zhang XM, Miao XP, Tan W, et al (2006). Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer. Zhongguo Yixue Kexueyuan Xuebao, 28, 119-23.
  40. Zhang XM, Zhong R, Liu L, et al (2011). Smoking and COX-2 functional polymorphisms interact to increase the risk of gastric cardia adenocarcinoma in Chinese population. PLoS One, 6, 21894. https://doi.org/10.1371/journal.pone.0021894
  41. Zhang XM, Zhong R, Zhang Z, et al (2011). Interaction of cyclooxygenase-2 promoter polymorphisms with Helicobacter pylori infection and risk of gastric cancer. Mol Carcinog, 50, 876-83. https://doi.org/10.1002/mc.20784
  42. Zhang YG, Huang J, Zhang J, et al (2010). RANTES gene polymorphisms and asthma risk: A meta-analysis. Arch Med Res, 41, 50-8. https://doi.org/10.1016/j.arcmed.2010.01.002
  43. Zhou Y, Li N, Zhuang W, et al (2007).P53 codon72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer, 121, 1481-6. https://doi.org/10.1002/ijc.22833
  44. Zhou Y, Hu W, Zhuang W, et al (2008). Interleukin-10-1082 promoter polymorphism associated with gastric cancer among Asians. Eur J Cancer, 44, 2648-54. https://doi.org/10.1016/j.ejca.2008.07.017

Cited by

  1. Associations between Single Nucleotide Polymorphisms of COX-2 and MMP-2 Genes and Colorectal Cancer Susceptibility in the Saudi Population vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4989
  2. Peroxisome Proliferator-Activated Receptor-Gamma Pro12Ala Polymorphism Could be a Risk Factor for Gastric Cancer vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2333
  3. Host pathogen interactions in Helicobacter pylori related gastric cancer vol.23, pp.9, 2017, https://doi.org/10.3748/wjg.v23.i9.1521